Quantum BioPharma Ltd is a biopharmaceutical company dedicated to building a portfolio of inventive assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, it is focused on the research and development of its lead compound, Lucid-MS. Lucid-MS is a patented new chemical entity shown to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. The company maintains a portfolio of strategic investments through its wholly owned subsidiary, which represents loans secured by residential or commercial property.

CEO

Zeeshan Saeed

Employees

Country

Canada

ISIN

CA35954B1076

WKN

000A3E2LR

Listings

0 Comments

Share your thoughts

FAQs

What is FSD Pharma stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange FSD Pharma stocks are traded under the ticker 0K9.STU.

When is the next FSD Pharma earnings date?▼

FSD Pharma is going to release the next earnings report on March 26, 2027.

What is FSD Pharma revenue for the last year?▼

FSD Pharma revenue for the last year amounts to 0 EUR.

What is FSD Pharma net income for the last year?▼

0K9.STU net income for the last year is -22.89M EUR.

How many employees does FSD Pharma have?▼

As of November 7, 2026, the company has 7 employees.

In which sector is FSD Pharma located?▼

FSD Pharma operates in the Health & Wellness sector.

When did FSD Pharma complete a stock split?▼

The last stock split for FSD Pharma was on October 16, 2019 with a ratio of 1:201.

Where is FSD Pharma headquartered?▼

FSD Pharma is headquartered in Toronto, Canada.